Reverse Engineering Ketamine to Create New Antidepressants
Researchers at Weill Cornell Medicine are reverse-engineering ketamine to develop next-generation antidepressants. By isolating the molecular pathways responsible for rapid mood elevation even as bypassing those that cause dissociative side ... Read More